Tessera
Folgen

Leen Vanheer

@leen-vanheer.bsky.social

Research fellow @lshtm.bsky.social working on malaria genomics and transmission blocking drugs | 🇧🇪 in 🇬🇧

2 Posts34 Follower54 Folgt
Leen Vanheer@leen-vanheer.bsky.social · last yr.

📢 Our paper is now out! Antimalarials stop symptoms, but do they also block onward transmission? We conducted a pooled analysis of 6 clinical trials in Mali with transmission endpoints 🦟 Thankful for great collaborators! journals.plos.org/plosmedicine...

The transmission blocking activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: A pooled analysis of individual participant data

Leen Vanheer and colleagues retrospectively analyzed individual participant data from six clinical trials of antimalarials to identify drug regimens that most effectively kill Plasmodium falciparum ga...

journals.plos.org

LSHTM Malaria Centre@lshtm-malaria.bsky.social · last yr.

From surviving malaria as a child to leading cutting-edge research on drug resistance in Africa. Dr Fitsum Tadesse @lshtm.bsky.social is fighting the parasite from both sides. A powerful story of science, and resilience 🧬🌍 Read his journey @NatureMicrobiol 📄 👉 bit.ly/4nWsb22

Fighting malaria as a patient and scientist - Nature Microbiology

Fitsum Tadesse was infected with malaria as a young child in Ethiopia and faced challenges to access efficacious treatment during a time of widespread drug resistance. Today, as a scientist in Africa,...

bit.ly

MRC Unit The Gambia at LSHTM@mrcunitgambia.bsky.social · last yr.

Professor Umberto D’Alessandro, #MRCG Unit Director shares insights on the first malaria medicine approved for babies. “Babies have been systematically excluded from clinical trials assessing the safety and efficacy of antimalarial treatments….” Read more: tinyurl.com/mwftby5h #EndMalaria

Expert Comment: First malaria medicine for babies approved | LSHTM

The first malaria treatment specifically developed for newborn babies and young infants has been approved for use. The approval, by Switzerland’s medical agency Swissmedic, of Coartem Baby

tinyurl.com